Hong Chen, Ph.D. Founder and CEO
Hong has over twenty years’ experience in CRO, biotech, pharmaceutical industry, and academic research with a strong track record of accomplishment. In particular, she has more than a decade of experience in large molecule bioanalysis.
Hong was a Scientific Director at Alliance Pharma, Sr. Scientist at Reaction Biology Corporation, a Principal Scientist at GlaxoSmithKline and Scientist at Stem Cell Therapeutics. Hong earned her doctorate degree in Molecular and Cellular Biology from Temple University. Subsequently, she did a postdoctoral fellowship at the University of Pennsylvania, Perelman School of Medicine in the laboratory of Dr. Mark Kahn.
Hong has published numerous scientific papers in the field of immunology, virology, molecular biology, and vascular biology in multiple scientific journals including Gene and Development, Proc. Natl. Acad. Sci. USA, Blood, Journal of Biologic Chemistry, and Molecular Cell Biology.